Trials / Completed
CompletedNCT01229059
Free Fatty Acid Induced Insulin Resistance
Assessment of the Time Course of Lipid Induced Insulin Resistance
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (actual)
- Sponsor
- German Diabetes Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study aims to explore time-dependent effects of lipid infusion an intramyocellular lipid metabolites and the induction of impaired insulin signaling.
Detailed description
Increased availability of free fatty acids impairs glucose disposal in young healthy humans. Patients with type 2 diabetes have reduced whole body glucose disposal, increased ectopic lipid deposition in skeletal muscle and the liver and impaired mitochondrial function. Recent studies suggest that lipid metabolites such as diacylglycerol (DAG), ceramides and long-chain acyl-coA represent the active mediators inducing insulin resistance. Possible targets are DAG-sensitive Proteinkinase C (PKC θ, PKC ε) which inhibit the insulin signaling cascade and ceramides which interfere with the insulin signaling cascade at Proteinkinase B/AKT. Prior studies raised controvesial evidence, thus, it is yet unclear, whether DAG or ceramides are the primary agents inducig lipid-induced insulin resistance. Therefore, the current study aims to explore the time course of the appearance of intramyocellular lipid compunds during lipid infusion in parallel assessing markers of impaired insulin action.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lipovenös lipid infusion | Lipid enriched infusions will be applied for 2-6 hours. |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2019-11-01
- Completion
- 2019-11-01
- First posted
- 2010-10-27
- Last updated
- 2023-08-15
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01229059. Inclusion in this directory is not an endorsement.